TScan Therapeutics Inc. (TCRX)
2.65
0.02 (0.76%)
At close: Jan 15, 2025, 3:59 PM
2.65
0.00%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -89.22M | -66.22M | -48.63M | -26.13M | -13.66M |
| Depreciation & Amortization | 5.36M | 5.14M | 3.33M | 1.23M | 519.00K |
| Stock-Based Compensation | 5.21M | 4.55M | 2.52M | 515.00K | 240.00K |
| Other Working Capital | 17.66M | -10.76M | -5.91M | 20.23M | 138.00K |
| Other Non-Cash Items | -315.00K | 260.00K | 9.16M | 2.00K | 78.00K |
| Deferred Income Tax | n/a | n/a | -9.16M | n/a | n/a |
| Change in Working Capital | 17.61M | -10.23M | -5.90M | 21.36M | 299.00K |
| Operating Cash Flow | -61.36M | -66.50M | -48.68M | -3.02M | -12.52M |
| Capital Expenditures | -3.15M | -4.22M | -9.94M | -4.24M | -1.25M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -77.61M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 20.00M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -60.76M | -4.22M | -9.94M | -4.24M | -1.25M |
| Debt Repayment | n/a | 29.35M | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 93.03M | -191.00K | 100.02M | 288.00K | 34.81M |
| Financial Cash Flow | 135.44M | 29.36M | 189.67M | 288.00K | 34.81M |
| Net Cash Flow | 13.33M | -41.37M | 131.05M | -6.97M | 21.04M |
| Free Cash Flow | -64.50M | -70.73M | -58.62M | -7.26M | -13.77M |